A phase 1 pharmacokinetic study of oral NEPA, the fixed combination of netupitant and palonosetron, in Chinese healthy volunteers

被引：0
|
作者：
Rui Chen
Hongyun Wang
Wen Zhong
Salvatore Chessari
Corinna Lanzarotti
Alberto Bernareggi
Pei Hu
机构：
[1] Peking Union Medical College Hospital,Clinical Pharmacology Research Center
[2] Helsinn Healthcare SA,Scientific Operations Division
来源：
Cancer Chemotherapy and Pharmacology | 2021年 / 87卷
关键词：
Antiemetic; NEPA; Netupitant; Palonosetron; Pharmacokinetics; China;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：387 / 396
页数：9
相关论文
共 50 条
  • [1] A phase 1 pharmacokinetic study of oral NEPA, the fixed combination of netupitant and palonosetron, in Chinese healthy volunteers
    Chen, Rui
    Wang, Hongyun
    Zhong, Wen
    Chessari, Salvatore
    Lanzarotti, Corinna
    Bernareggi, Alberto
    Hu, Pei
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2021, 87 (03) : 387 - 396
  • [2] Effect of food and age on the pharmacokinetics of NEPA (a fixed-dose combination of netupitant and palonosetron) in healthy volunteers
    Calcagnile, S.
    Lanzarotti, C.
    Gutacker, M.
    Jakob-Rodamer, V.
    Kammerer, K. P.
    EUROPEAN JOURNAL OF CANCER, 2013, 49 : S276 - S276
  • [3] Safety and efficacy of NEPA, an oral fixed combination of netupitant and palonosetron, in older patients
    Aapro, Matti
    Jordan, Karin
    Gralla, Richard J.
    Rizzi, Giada
    Rossi, Giorgia
    Palmas, Marco
    Alyasova, Anna V.
    Lisyanskaya, Alla S.
    Bosnjak, Snezana M.
    Hesketh, Paul J.
    JOURNAL OF GERIATRIC ONCOLOGY, 2017, 8 (01) : 56 - 63
  • [4] Safety of an Oral Fixed Combination of Netupitant and Palonosetron (NEPA): Pooled Data From the Phase II/III Clinical Program
    Aapro, Matti
    Hesketh, Paul J.
    Jordan, Karin
    Gralla, Richard J.
    Rossi, Giorgia
    Rizzi, Giada
    Palmas, Marco
    ONCOLOGIST, 2016, 21 (04): : 494 - 502
  • [5] Effects of NEPA (novel combination of netupitant and palonosetron) on ECG of healthy volunteers: A randomized, controlled, thorough ECG trial.
    Spinelli, Tulla
    Moresino, Cecilia
    Baumann, Sybille
    Timmer, Wolfgang
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [6] Pharmacokinetic (PK) study of a single oral dose of NEPA in Chinese healthy volunteers (HVs)
    Chen, R.
    Chessari, S.
    Lanzarotti, C.
    Bernareggi, A.
    Hu, P.
    ANNALS OF ONCOLOGY, 2017, 28
  • [7] Comparison of pharmacokinetic (PK) profiles of netupitant (NETU) and palonosetron (PALO) in Chinese and Caucasian healthy volunteers (HV)
    Aapro, M.
    Bernareggi, A.
    ANNALS OF ONCOLOGY, 2017, 28 : 159 - 159
  • [8] Review of oral fixed-dose combination netupitant and palonosetron (NEPA) for the treatment of chemotherapy-induced nausea and vomiting
    Lorusso, Vito
    Karthaus, Meinolf
    Aapro, Matti
    FUTURE ONCOLOGY, 2015, 11 (04) : 565 - 577
  • [9] Phase III study of NEPA, a fixed combination of netupitant and palonosetron, versus an aprepitant regimen for prevention of chemotherapy-induced nausea and vomiting (CINV).
    Zhang, Li
    Lu, Shun
    Feng, Ji Feng
    Dechaphunkul, Arunee
    Chessari, Salvatore
    Lanzarotti, Corinna
    Jordan, Karin
    Aapro, Matti S.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [10] No Evidence Of Increased Cyclophosphamide Toxicity Associated With The Antiemetic Agent NEPA, a Fixed-Dose Combination Of Netupitant and Palonosetron
    Schwartzberg, Lee
    Oprean, Cristina
    Cardona-Huerta, Servando
    Rizzi, Giada
    Rossi, Giorgia
    Palmas, Marco
    Karthaus, Meinolf
    Aapro, Matti
    BLOOD, 2013, 122 (21)
12345